- conflicts or gaps
- [[{"field": {"value": "funding.total_raised_usd", "source_urls": ["https://en.globes.co.il/en/article-invitea-buys-clear-genetics-for-50m-1001307274", "https://www.calcalistech.com/ctech/articles/0,7340,L-3773556,00.html", "https://www.cbinsights.com/company/clear-genetics", "https://www.startuphub.ai/startups/clear-genetics"]}, "issue": {"value": "Total venture funding reported as $2.5M (Globes), $2.52M (Pitchbook via CTech), $2.62M (CB Insights), and $3M (StartupHub.ai). No primary-source round-by-round amounts or dates found.", "source_urls": ["https://en.globes.co.il/en/article-invitea-buys-clear-genetics-for-50m-1001307274", "https://www.calcalistech.com/ctech/articles/0,7340,L-3773556,00.html", "https://www.cbinsights.com/company/clear-genetics", "https://www.startuphub.ai/startups/clear-genetics"]}}, {"field": {"value": "funding.investors_all", "source_urls": ["https://en.globes.co.il/en/article-invitea-buys-clear-genetics-for-50m-1001307274", "https://www.cbinsights.com/company/clear-genetics"]}, "issue": {"value": "Primary sources (Globes, CTech) list Y Combinator, iAngels, and Meron Capital. CB Insights additionally lists Anne Wojcicki, LionBird, and Arkin Digital Health without corroborating primary announcements.", "source_urls": ["https://en.globes.co.il/en/article-invitea-buys-clear-genetics-for-50m-1001307274", "https://www.cbinsights.com/company/clear-genetics"]}}, {"field": {"value": "founders", "source_urls": ["https://www.ycombinator.com/companies/clear-genetics", "https://www.calcalistech.com/ctech/articles/0,7340,L-3773556,00.html"]}, "issue": {"value": "Y Combinator and Globes list three co-founders (Moran Snir, Guy Snir, Motti Shohat M.D.). CTech acquisition article names only Moran and Guy Snir.", "source_urls": ["https://www.ycombinator.com/companies/clear-genetics", "https://en.globes.co.il/en/article-invitea-buys-clear-genetics-for-50m-1001307274", "https://www.calcalistech.com/ctech/articles/0,7340,L-3773556,00.html"]}}, {"field": {"value": "identity.website", "source_urls": ["https://cleargenetics.com", "https://www.invitae.com/us/providers/gia-chatbot"]}, "issue": {"value": "cleargenetics.com currently serves Invitae Gia product content; Clear Genetics brand appears fully absorbed post-acquisition.", "source_urls": ["https://cleargenetics.com", "https://www.invitae.com/us/providers/gia-chatbot"]}}, {"field": {"value": "exit_status.post_exit", "source_urls": ["https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/d859163d8k.htm", "https://ir.labcorp.com/news-releases/news-release-details/labcorp-finalizes-acquisition-select-assets-invitae"]}, "issue": {"value": "After Invitae's 2024 Chapter 11, Labcorp acquired Invitae's genetic-testing and digital-health assets. Public filings confirm the asset sale but do not explicitly name Clear Genetics, Inc. or Gia as separate line items; current legal entity status of Clear Genetics is unclear.", "source_urls": ["https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/d859163d8k.htm", "https://ir.labcorp.com/news-releases/news-release-details/labcorp-finalizes-acquisition-select-assets-invitae"]}}, {"field": {"value": "products[0].usage_metrics", "source_urls": ["https://cleargenetics.com"]}, "issue": {"value": "Post-acquisition usage stats on cleargenetics.com (100,000+ patients, 92% satisfaction, 80% engagement rate) are undated and sourced from Invitae-branded page; may reflect cumulative Invitae-era usage rather than pre-acquisition Clear Genetics metrics.", "source_urls": ["https://cleargenetics.com"]}}, {"field": {"value": "identity.sector", "source_urls": ["https://yc-oss.github.io/api/batches/winter-2017/clear-genetics.json", "https://www.prnewswire.com/news-releases/invitae-to-acquire-clear-genetics-300955258.html"]}, "issue": {"value": "YC OSS subindustry is Consumer Health and Wellness, but product and customers were primarily B2B health systems, clinics, and commercial labs.", "source_urls": ["https://yc-oss.github.io/api/batches/winter-2017/clear-genetics.json", "https://www.prnewswire.com/news-releases/invitae-to-acquire-clear-genetics-300955258.html"]}}, {"field": {"value": "products.initial_focus", "source_urls": ["https://en.globes.co.il/en/article-invitea-buys-clear-genetics-for-50m-1001307274"]}, "issue": {"value": "Globes reports company initially focused on pre-pregnancy genetic counseling, then expanded to cancer-treatment personalization at customer request; no independent primary confirmation of pivot timeline.", "source_urls": ["https://en.globes.co.il/en/article-invitea-buys-clear-genetics-for-50m-1001307274"]}}]]
- source urls
- ["https://cleargenetics.com", "https://en.globes.co.il/en/article-invitea-buys-clear-genetics-for-50m-1001307274", "https://ir.labcorp.com/news-releases/news-release-details/labcorp-finalizes-acquisition-select-assets-invitae", "https://www.calcalistech.com/ctech/articles/0,7340,L-3773556,00.html", "https://www.cbinsights.com/company/clear-genetics", "https://www.genomeweb.com/business-news/invitae-acquire-genetic-counseling-chatbot-developer-50m", "https://www.insideprecisionmedicine.com/news-and-features/invitae-to-acquire-clear-genetics-for-50m-adding-chatbots-for-genetic-counseling/", "https://www.invitae.com/us/providers/gia-chatbot", "https://www.ivc-online.com/Google-Card?id=550f8c96-ff9c-e711-80d7-00155d0b832c", "https://www.prnewswire.com/news-releases/invitae-to-acquire-clear-genetics-300955258.html", "https://www.sec.gov/Archives/edgar/data/1501134/000119312519290995/d819557d8k.htm", "https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/d859163d8k.htm", "https://www.startuphub.ai/startups/clear-genetics", "https://www.ycombinator.com/companies/clear-genetics", "https://yc-oss.github.io/api/batches/winter-2017/clear-genetics.json"]